Korro Bio, Inc. (KRRO)
NASDAQ·Healthcare·Biotechnology
$14.55
-1.36%
Mkt Cap $115.83M
Analyst Ratings
No recent rating data.
Price Target (16 analysts)
$15.00
Range $15.00 – $15.00
Implied Upside
+3.1%
Consensus $15.00 vs current $14.55
NASDAQ·Healthcare·Biotechnology
$14.55
-1.36%
Mkt Cap $115.83M
No recent rating data.
Price Target (16 analysts)
$15.00
Range $15.00 – $15.00
+3.1%
Consensus $15.00 vs current $14.55